Overview
Daniel Pham practices practicing medicine in Australia.
Their clinical expertise encompasses Renal Cell Carcinoma (RCC) and Bladder Cancer.
They are actively involved in clinical research, co-authoring 28 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Daniel L. Pham
Is Daniel L. Pham a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Daniel L. Pham is classified as an Experienced expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Daniel L. Pham participate in research or clinical trials?
Yes. Daniel L. Pham has published 28 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Daniel L. Pham's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bladder CancerPham isExperienced. Learn about Bladder Cancer.
- Renal Cell Carcinoma (RCC)Pham isExperienced. Learn about Renal Cell Carcinoma (RCC).